Recent news on Raloxifene

Urge activation of cancer study  -  May 24, 2007
Hendersonville Times News,The Study to Evaluate Letrozole and Raloxifene, or STELLAR, would evaluate the effectiveness of a drug that could reduce risk of breast cancer in women at

Top Drugs to Prevent Breast Cancer  -  May 22, 2007
DentalPlans.com,Like Tamoxifen, Raloxifene is a pill taken daily that affects the estrogen levels in order to prevent them from attaching to cancer cells.

Best Breast Cancer Prevention Drugs  -  May 21, 2007
DentalPlans.com,Another SERM that been shown to be successful in the prevention of breast cancer is Raloxifene. Raloxifene is traditionally used to help prevent

Letter: Release funding for breast cancer research  -  May 22, 2007
Billings Gazette,...treatment and prevention, I wanted to draw your attention to the pending fate of the Study to Evaluate Letrozole and Raloxifene (STELLAR) or NSABP P-4,

Raloxifene prevents breast cancer  -  Apr 27, 2007
Baku Sun,At least 2 million women might benefit from raloxifene’s cancer-reducing effects, researchers said Monday in announcing initial results of the $88 million

Dr. Bill Elliott: Lifestyle changes can help prevent bone loss  -  May 21, 2007
Marin Independent-Journal,Raloxifene (Evista) is a selective estrogen receptor modulator (SERM) that has some estrogen-like effects including strengthening bone, but is associated

Letters | Save this breast-cancer research  -  May 21, 2007
Philadelphia Daily News,So when STELLAR, or the Study to Evaluate Letrozole and Raloxifene, is threatened with cancellation, the NSABP, or National Surgical Adjuvant Breast and

Breast Cancer Prevention Trial in Limbo  -  May 8, 2007
Journal of American Medical Association (subscription),The $100 million phase 3 randomized, double-blind Study to Evaluate Letrozole and Raloxifene (STELLAR) trial, which would involve about 13 000 women and

Let's Make May the Month to Tame Osteoporosis Hype  -  May 23, 2007
Women's eNews,Raloxifene increases bone mineral density. However, it has been proven to reduce only vertebral fractures, not hip fractures, and it involves risks not

Release funding for cancer-drug study  -  May 16, 2007
Bloomington Pantagraph,I wanted to draw your attention to the pending fate of the Study to Evaluate Letrozole and Raloxifene, or NSABP P-4, a new clinical study designed to

Use of Alendronate After 5 Years of Treatment  -  May 8, 2007
Journal of American Medical Association (subscription),Ettinger B, Black DM, Mitlak BH, et al, Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of vertebral fracture risk in

uterine fibroid tumors  -  May 16, 2007
American Family PhysicianThe selective estrogen receptor modulator raloxifene (Evista) has been shown in one small study to decrease tumor size in postmenopausal women; however,

Low- vs High-Dose Estradiol Vaginal Ring in Treatment of Sexual ...  -  May 15, 2007
Journal of American Medical Association (subscription),...show on women's health from Pfizer Pharmaceuticals and having served on an internal medicine advisory board for Eli Lilly regarding raloxifene.

Guidelines Urge Women To Curb Heart, Stroke Risk  -  May 3, 2007
Jamestown Post Journal,Nor should so-called SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk of that disease.

Tamoxifen Protects Certain Women at High Risk for Breast Cancer  -  May 2, 2007
Forbes,Another drug, raloxifene, also has fewer side effects but does not prevent noninvasive breast cancer, whereas tamoxifen works on both, Brooks said.

Wyeth: optimizing bazedoxifene's lifecycle strategy  -  Apr 25, 2007
Pharmaceutical Business ReviewOther challenges to bazedoxifene in the osteoporosis market include the potential gain, by class competitor Evista, (raloxifene, Eli Lilly), of a label for

Wyeth: optimizing bazedoxifene's lifecycle strategy  -  26 Apr 2007
Pharmaceutical Business ReviewOther challenges to bazedoxifene in the osteoporosis market include the potential gain, by class competitor Evista, (raloxifene, Eli Lilly), of a label for

Decline In Breast Cancer Incidence Sustained In 2004, Study Says ...  -  Apr 24, 2007
Medical News Today (press release),Experts say that other contributing factors could include increased use of medications that lower breast-cancer risk, including the bone drug raloxifene,

Remifemin(R)/Black Cohosh Reduces Menopausal Symptoms and Protects ...  -  Apr 24, 2007
Wisbusiness.com,The study also demonstrated that no significant interaction between tamoxifen/raloxifene use and use of any herbal preparation or black cohosh use was

Remifemin(R)/Black Cohosh Reduces Menopausal Symptoms and Protects ...  -  Apr 23, 2007
PR-Inside.com (Pressemitteilung),The study also demonstrated that no significant interaction between tamoxifen/raloxifene use and use of any herbal preparation or black cohosh use was

How Corrupt is Malcolm Gladwell?  -  Mar 31, 2007
CounterPunch,Gladwell's piece culminated in a plug for Eli Lilly's new drug Raloxifene, which was about to be marketed as Evista. "Before very long," wrote Gladwell,

Decline in Breast Cancer Incidence Sustained in 2004, Study Says ...  -  Apr 20, 2007
Kaiser network.org,Experts say that other contributing factors could include increased use of medications that lower breast-cancer risk, including the bone drug raloxifene,

How to prevent osteoporosis  -  Apr 20, 2007
iAfrica.com,Raloxifene acts on oestrogen receptors and increase bone mass without causing vaginal bleeding and without any apparent effect on the breast or endometrium

Sharp decline in breast cancer linked to HRT, study shows  -  Apr 19, 2007
TheHeart.Org,These drugs include tamoxifen and raloxifene, and there is some evidence for beneficial effects of nonsteroidal anti-inflammatory drugs, statins,

Why less breast cancer?  -  Apr 19, 2007
Health24.com,The researchers also checked for environmental factors and the use of breast cancer drugs such as tamoxifen and raloxifene. But none of these factors had

Questions About Drop  -  Apr 18, 2007
Wall Street Journal (subscription),In addition, changes in medication use, such as the bone drug raloxifene, aspirin and anti-inflammatory drugs and the use of calcium supplements and Vitamin

Ariad and Amgen in battle over biotech patent  -  Apr 18, 2007
BiopharmaReporter.com,In the Lilly case last May, Ariad alleged that Lilly's septic shock drug Xigris (drotrecogin alfa) and Evista (raloxifene), a treatment for osteoporosis,

Cancer and Staying Fit  -  Mar 31, 2007
NewsweekModern miracle drugs like tamoxifen and raloxifene routinely cut risk for breast cancer in women whose medical histories or genes make them especially

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Earthtimes.orgAmylin Pharmaceuticals) Cialis(R) (tadalafil, Lilly) Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R)

Most US Women Face Heart, Stroke Risk  -  25 Feb 2007
Christian PostNor should so-called SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk of that disease.

Boca cardiologist “surprisedâ€? at some of the new AHA guidelines ...  -  25 Feb 2007
Boca Raton News,...use menopausal therapies such as hormone replacement therapy (HRT) or selective estrogen receptor modulators (SERMs) such as raloxifene or tamoxifene to

New Guidelines for Women to Prevent Heart Disease  -  Feb 20, 2007
13WHAM-TV,3- Hormone replacement therapy and selective estrogen receptor modulators such as the osteoporosis drug Raloxifene-- are not recommended.

Women at higher risk of heart disease than they might think  -  Feb 20, 2007
Honolulu Advertiser,Research shows estrogen-progestin drugs and the modulator drugs such as Raloxifene can promote clotting. Evidence on the safety of transdermal estrogen

NCCN Updates Breast Cancer Risk Reduction Guidelines  -  Feb 13, 2007
PharmaLive.com (press release),One major change in the 2007 version of the guidelines is the addition of raloxifene (Evista(R), Eli Lilly) as a breast cancer risk reduction agent for

Patient Information Page from The Hormone Foundation  -  Feb 6, 2007
Journal of Clinical Endocrinology and Metabolism,Raloxifene is approved by the FDA for the prevention and treatment of osteoporosis (brittle bones) in postmenopausal women (aged 51 and older).

Hard-to-treat breast cancer impacting Latinas  -  Feb 5, 2007
Chicago Sun-Times,This means drugs that counter the effects of estrogen, such as Tamoxifen, Raloxifene or aromatase inhibitors, are useless against them.

Cancer Research Could Be Affected By Cuts to NCI Funding  -  Jan 30, 2007
Kaiser network.org,...by federal spending cuts have made key discoveries in the past, such as the therapeutic value of tamoxifin and raloxifene at preventing breast cancer.

An aspirin a day keeps heart disease away  -  Feb 23, 2007
Indian Catholic,The guidelines discourage women from using hormone replacement therapy and selective estrogen receptor modulators such as the osteoporosis drug raloxifene

Most US women face heart, stroke risk  -  Feb 22, 2007
Jordan Falls News,Nor should so-called SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk of that disease.

Hour of exercise a day can save women's lives  -  Feb 21, 2007
UK Express,The guidelines also said hormone replacement therapy and selective oestrogen receptor modulators – like the osteoporosis drug Raloxifene – are not

Medipattern adds to Reseller Network, Providing Technology to ...  -  Feb 21, 2007
SYS-CON Media,According to this landmark study, drugs that counter the effects of estrogen, such as Tamoxifen, Raloxifene, or aromatase inhibitors (a class of drugs used

New guidelines to protect women's hearts  -  Feb 20, 2007
ABC7Chicago.com,Hormone replacement therapy and selective estrogen receptor modulators, such as the osteoporosis drug raloxifene, are not recommended to prevent heart

New US heart guidelines for women stress aspirin  -  Feb 20, 2007
San Diego Union Tribune,Hormone replacement therapy and selective estrogen receptor modulators such as the osteoporosis drug raloxifene are not recommended to prevent heart disease

Women's heart risk rises with age  -  Feb 20, 2007
Asbury Park Press,...the modulator drugs such as Raloxifene can promote clotting. Evidence on the safety of transdermal estrogen patches is still sketchy, Mosca says.

Women's heart risk underestimated  -  Feb 20, 2007
WZZM,Research shows estrogen-progestin drugs and the modulator drugs such as raloxifene can promote clotting. Evidence on the safety of transdermal estrogen

Updated guidelines advise focusing on women's lifetime heart risk  -  Feb 20, 2007
PressZoom (press release),...menopausal therapies such as hormone replacement therapy ( HRT ) or selective estrogen receptor modulators ( SERMs ) such as raloxifene or tamoxifene to

New health warning for women Experts say take action to reduce ...  -  Feb 20, 2007
Cleveland Plain Dealer,Nor should so-called SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk of that disease.

Women urged to pamper their hearts  -  Feb 20, 2007
Cape Cod Times,Nor should SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk.

An aspirin a day keeps heart disease away  -  Feb 20, 2007
News-Medical.net,The guidelines discourage women from using hormone replacement therapy and selective estrogen receptor modulators such as the osteoporosis drug raloxifene

Women urged to cut heart, stroke risks  -  Feb 19, 2007
Boston Globe,...disease -- nor should so-called SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk of that disease.

For women, aspirin a day could keep stroke away  -  Feb 19, 2007
DetNews.com,Nor should so-called SERM drugs, such as tamoxifen and raloxifene, which are used to prevent breast cancer in women at high risk.

Aspirin and Lipid Lowering Pushed to Prevent Heart Disease in Women  -  Feb 19, 2007
MedPage Today,...selective estrogen receptor modulators such as tamoxifen or raloxifene (Evista), or for supplements such as folic acid, beta carotene, vitamins E or C

For Breast Cancer Patients Early Switch To An Aromatase Inhibitor ...  -  Feb 16, 2007
Medical News Today (press release),Despite this risk, tamoxifen and another drug in this class, raloxifene, remain an extensively used and popular treatment.

Switching Breast Cancer Drug Increases Survival  -  Feb 12, 2007
Lex 18,The authors explain tamoxifen and a similar drug, raloxifene (Evista), are typically prescribed to women with estrogen-sensitive breast cancers because

Early switch to aromatase inhibitor ups survival, study says  -  Feb 12, 2007
Pharma Times (subscription),...generic versions on the market and another drug in this class, Eli Lilly's Evista (raloxifene), "remain an extensively used and popular treatment."

Switching to newer breast cancer drugs boosts survival  -  Feb 12, 2007
Cancerfacts.com,...by modifying estrogen, and despite its risks, tamoxifen and a similar drug in this class, raloxifene, remain a common added treatment after surgery.

Aggressive breast cancer hits Latinas  -  Feb 5, 2007
Houston Chronicle,This means drugs that counter the effects of estrogen, such as Tamoxifen, Raloxifene or aromatase inhibitors, are useless against them.

Studies Examine Race Factors in Certain Leg Amputations ...  -  Feb 6, 2007
Kaiser network.org,The tumors are not fueled by estrogen, so they cannot be treated with estrogen-blocking drugs, such as tamoxifen or raloxifene, and the breast cancer drug

Full Text  -  Feb 1, 2007
Science Magazine (subscription)...these tumors are not fueled by estrogen and do not respond to drugs such as tamoxifen and raloxifene that cut off their supply of the hormone.

Proposal would cut cancer institute budget again  -  Jan 28, 2007
USA TodayTheir studies showed that the drugs tamoxifen and raloxifene may prevent breast cancer, for example. Researchers had hoped to begin the next phase of study,

Kyphoplasty: An Assessment of a New Technology  -  Feb 12, 2007
AJNR (subscription),Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Earthtimes.orgAmylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride,

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Yahoo! News (press release)Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin injection, Lilly) Gemzar® (gemcitabine hydrochloride,

Raloxifene vs Tamoxifen  -  Jan 16, 2007
Journal of American Medical Association (subscription),To the Editor: Dr Vogel and colleagues 1 reported the results of the Study of Tamoxifen and Raloxifene (STAR) P-2 trial. I was disappointed that in the

Seven For 2007: Seven Things You Should Know About Breast Cancer ...  -  Jan 7, 2007
Medical News Today (press release),Taking the anti-estrogen drug tamoxifen or raloxifene may cut the incidence of breast cancer in women at increased risk for the disease.

Approaches to reduce breast-cancer risk  -  Jan 5, 2007
Earthtimes.orgTaking the anti-estrogen drug tamoxifen or raloxifene may cut the incidence of breast cancer for women with an increased risk.

Ontario government invests in bone health  -  Jan 10, 2007
CNW Telbec (Communiqués de presse),Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT

Nancy Whelan: Osteoporosis medications can have side effects  -  Jan 5, 2007
Sebastian Sun (subscription),Bisphosphonate drugs (alendronate, ibandronate, risedronate, calcitonin, estrogens and raloxifene) work by affecting the bone remodeling cycle.

Eli Lilly confirms UK plant closure  -  Jan 2, 2007
OutSourcing-Pharma.com,The facility was responsible for the manufacture of four of Eli Lilly's key drugs – Cialis (tadalafil), Evista (raloxifene hydrochloride),

Women gained ground in 2006  -  Dec 31, 2006
Connecticut Post,Less controversial was an announcement by the National Cancer Institute that the drug raloxifene, previously used to prevent and treat osteoporosis,

Hormone-breast cancer link no surprise to scientists like Dr. Jordan  -  Dec 31, 2006
Seattle Post Intelligencer,...the risk of hip fractures, but there are now many different alternatives for women to maintain bone density, such as bisphosphonates or raloxifene.

Health Experts React To Report Linking 7% Drop In Breast Cancer ...  -  Dec 20, 2006
Medical News Today (press release),Ravdin said that it is possible that other factors -- including anti-estrogen drugs, such as raloxifene; statin drugs that reduce cholesterol; or drugs used

Alendronate Improves Screw Fixation in Osteoporotic Bone  -  Jan 2, 2007
Journal of Bone and Joint Surgery (subscription)Cao Y, Mori S, Mashiba T, Westmore MS, Ma L, Sato M, Akiyama T, Shi L, Komatsubara S, Miyamoto K, Norimatsu H. Raloxifene, estrogen, and alendronate affect

HORMONES AND CANCER: ASSESSING THE RISKS  -  26 Dec 2006
Amherst Times.com,...the risk of hip fractures, but there are now many different alternatives for women to maintain bone density, such as bisphosphonates or raloxifene.

Premenopausal women at increased risk of breast cancer: Raloxifene ...  -  Dec 22, 2006
Xagena.it,Raloxifene ( Evista ) is a promising breast cancer prevention agent in postmenopausal women at increased risk for breast cancer. The effects of Raloxifene

Raloxifene may increase fatal stroke risk in postmenopausal women  -  Dec 15, 2006
TheHeart.Org,Chicago, IL - Further secondary analysis from the Raloxifene Use for the Heart (RUTH) trial shows that although the overall risk for stroke was not

Eli Lilly and Company Submits New Drug Application for EVISTA for ...  -  Dec 7, 2006
PR Newswire (press release),Information About EVISTA(R) EVISTA(R) (raloxifene HCl) is a prescription medication that prevents and treats osteoporosis in women past menopause.

US breast-cancer guidelines updated  -  Dec 13, 2006
United Press InternationalOne change is that Eli Lilly's Evista (raloxifene) is now recommended for use in reducing the risk of invasive breast cancer in postmenopausal women with

Eli Lilly and Company Submits New Drug Application for EVISTA for ...  -  Dec 7, 2006
Drug Newswire (press release),Postmenopausal women with osteoporosis in the Multiple Outcomes of Raloxifene Evaluation (MORE) and Continuing Outcomes Relevant to EVISTA (CORE) trials.

Researchers devise method to search for breast cancer drugs  -  Nov 27, 2006
LabTechnologist.com,Two of the current selective estrogen receptor modulator (SERM) drugs, tamoxifen and Eli Lilly's Evista (raloxifene), are antioestrogens and are used for

TCD researchers chart chemical space in the search for new breast ...  -  Nov 27, 2006
innovations report,Two of the current Selective Estrogen Receptor Modulator (SERM) drugs, Tamoxifen and Raloxifene, are antiestrogens and are used for treating breast cancer

Eli Lilly Submits New Drug Application for Evista®  -  Dec 11, 2006
Cancer Consultants (press release),Eli Lilly has submitted a new drug application (NDA) for Evista (raloxifene HCl) to reduce the risk of invasive breast cancer in postmenopausal women at a

Reduced Dietary Fat Intake May Decrease Breast Cancer Recurrence  -  Dec 18, 2006
Science Daily (press release)Raloxifene After Tamoxifen Not Beneficial, According To New Study (February 20, 2002) -- Taking raloxifene after five years of tamoxifen therapy does not

NCCN Updates Breast Cancer Guidelines  -  Dec 13, 2006
PharmaLive.com (press release),Based on results from the NSABP Study of Tamoxifen and Raloxifene (STAR) trial, a panel of world-renowned experts added Raloxifene (Evista, Eli Lilly and

Health Experts React To Report Linking 7% Drop In Breast Cancer ...  -  Dec 20, 2006
Medical News Today (press release),Ravdin said that it is possible that other factors -- including anti-estrogen drugs, such as raloxifene; statin drugs that reduce cholesterol; or drugs used

Progress Reported Toward Development of a Breast Cancer Vaccine  -  Dec 17, 2006
Drug Newswire (press release),Current approaches to preventing breast cancer either use drugs that may have significant side effects (eg, tamoxifen, raloxifene, and a new generation of

Breast cancer cases plunge, study finds  -  Dec 15, 2006
Chicago Tribune,Factors other than mammography might include the use of anti-estrogen drugs such as raloxifene for osteoporosis, statin drugs that reduce cholesterol,

Breast cancer reduction may be tied to less hormone therapy  -  Dec 15, 2006
Kansas City Star,Other factors might include not only mammography but also the use of anti-estrogen drugs such as raloxifene for osteoporosis, statin drugs that reduce

Breast cancer rate dropped with halt in hormone use  -  Dec 14, 2006
Houston Chronicle,3 percent decline in the use of mammograms but increases in anti-inflammatory drugs, the new cancer-prevention drug raloxifene and calcium supplements.

Breast-cancer cases fall  -  Dec 15, 2006
Columbus Dispatch,Other factors might include not only mammography but also the use of antiestrogen drugs such as raloxifene for osteoporosis, statin drugs that reduce

Lilly opts for caution with 2007 earnings estimates  -  Dec 8, 2006
Pharma Times (subscription),Lilly also said that it is seeking approval for Evista (raloxifene), its osteoporosis treatment, to be used for the prevention of breast cancer for certain

Doctor: Osteoporosis should be a concern for women who smoke ...  -  Dec 7, 2006
49abcnews.com,Currently, bisphosphonates -- alendronate, ibandronate and risedronate -- calcitonin, estrogens, parathyroid hormone and raloxifene are approved by the US

Fighting Alzheimer's  -  Dec 4, 2006
WFtv.com,EVISTA: The osteoporosis drug raloxifene (Evista) is now being tested to see if it can stop Alzheimer's disease in its tracks and/or prevent it from

Health Calendar  -  Nov 27, 2006
DetNews.com,Raloxifene, Sharing & Caring program for breast cancer survivors. Sponsored by AstraZeneca Oncology. 7-9 pm Beaumont Cancer Center, 3577 W. 13 Mile,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)Lilly ICOS LLC Cymbalta® (duloxetine hydrochloride, Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),Amylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional